Organizations highlight developments in honor of Familial Chylomicronemia Syndrome Awareness Day

Friday marks the second annual Familial Chylomicronemia Syndrome Awareness Day, a day dedicated to raising global observance of the challenges associated with the rare genetic disease and the critical need for treatment.
Familial chylomicronemia syndrome (FCS) is estimated to occur in 1 in 1 million to 2 million people, according to the National Pancreas Foundation, and can be diagnosed at any age. The disease is caused by impaired function of the enzyme lipoprotein lipase, which results in elevated triglyceride levels and significant risk and disease burden, including unpredictable and

Source link

Related posts

Indispensable role of β-arrestin2 in the protection of remifentanil preconditioning against hepatic ischemic reperfusion injury


Permeability of the small intestinal mucus for physiologically relevant studies: Impact of mucus location and ex vivo treatment


A prospective phase II study of pre-operative chemotherapy then short-course radiotherapy for high risk rectal cancer: COPERNICUS


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy